Research map: Factors Facilitating Adoption of Pharmacogenetic Testing by Prescribers of Antidepressants in Four US Health Systems: A Multi-Site Cross-Sectional PGx Implementation Science Study

Back to the article

Papers in this map

  1. Three Approaches to Qualitative Content Analysis · Hsiu-Fang Hsieh · 2005 · 45270 citations · Cited by this paper
  2. Data-Driven Clinical Phenotyping of Adult Epilepsy Using Latent Class Analysis: A Regional Cohort Study from Southern Kazakhstan · 2026 · Related
  3. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science · Laura J. Damschroder · 2009 · 15462 citations · Cited by this paper
  4. Multimodal Correlates of Longitudinal Functional Decline in Behavioral Variant Frontotemporal Dementia (bvFTD) · 2026 · Related
  5. Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda · Enola K. Proctor · 2010 · 9353 citations · Cited by this paper
  6. Integration of Precision Medicine into ERAS Pathways: A Conceptual Framework, Current Feasibility and Challenges · 2026 · Related
  7. The updated Consolidated Framework for Implementation Research based on user feedback · Laura J. Damschroder · 2022 · 4381 citations · Cited by this paper
  8. Total Hip Arthroplasty in Patients with BMI ≥ 30 kg/m2: BMI Evolution, Planning Accuracy, Restoration of Anthropometric Parameters and Clinical Outcomes · 2026 · Related
  9. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems · Lou Atkins · 2017 · 4107 citations · Cited by this paper
  10. Integration of Clinical, Cytokine, and Ultrasound Data Using Machine Learning Reveals a Multidimensional Inflammatory Signature in Polymyalgia Rheumatica · 2026 · Related
  11. Psychometric assessment of three newly developed implementation outcome measures · Bryan Jeffrey Weiner · 2017 · 3075 citations · Cited by this paper
  12. Advancing the science of genomic learning healthcare systems · 2025 · Related
  13. An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine · Michelle Whirl‐Carrillo · 2021 · 830 citations · Cited by this paper
  14. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study · Jesse Joachim Swen · 2023 · 566 citations · Cited by this paper
  15. Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process · Kelly E. Caudle · 2014 · 451 citations · Cited by this paper
  16. Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies · GENDEP Investigators · 2013 · 253 citations · Cited by this paper
  17. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines · H. Abdullah-Koolmees · 2021 · 233 citations · Cited by this paper
  18. Pharmacogenetic Tests and Depressive Symptom Remission: A Meta-Analysis of Randomized Controlled Trials · Chad Bousman · 2018 · 208 citations · Cited by this paper
  19. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder · David W. Oslin · 2022 · 205 citations · Cited by this paper
  20. Coincidence analysis: a new method for causal inference in implementation science · Rebecca Whitaker · 2020 · 155 citations · Cited by this paper
  21. A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care · Santenna Chenchula · 2024 · 66 citations · Cited by this paper
  22. Clinical implementation of preemptive pharmacogenomics in psychiatry · Μαρία Σκώκου · 2024 · 61 citations · Cited by this paper
  23. Patient Perspectives Following Pharmacogenomics Results Disclosure in an Integrated Health System · Amy A. Lemke · 2018 · 60 citations · Cited by this paper
  24. Challenges and opportunities associated with rare-variant pharmacogenomics · Yitian Zhou · 2022 · 55 citations · Cited by this paper
  25. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study · Brittany A. Borden · 2018 · 36 citations · Cited by this paper
  26. Robustness and Model Selection in Configurational Causal Modeling · Veli‐Pekka Parkkinen · 2021 · 36 citations · Cited by this paper
  27. A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling · Josiah D. Allen · 2022 · 36 citations · Cited by this paper
  28. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology · Sharon P. Shriver · 2024 · 35 citations · Cited by this paper
  29. Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis · Danyang Li · 2024 · 32 citations · Cited by this paper
  30. Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand? · Elena Peruzzi · 2023 · 29 citations · Cited by this paper
  31. Implementation of pharmacogenomics: Where are we now? · Samantha J. Medwid · 2022 · 22 citations · Cited by this paper
  32. Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation · Romy Mosch · 2024 · 21 citations · Cited by this paper
  33. Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial · Lei Xu · 2024 · 19 citations · Cited by this paper
  34. Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice · Florine M. Wiss · 2024 · 13 citations · Cited by this paper
  35. Stimulant, Antidepressant, and Opioid Telehealth Prescription Trends Between 2019 and 2022 · Ashwini Nagappan · 2024 · 13 citations · Cited by this paper
  36. Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ” · Kelly E. Caudle · 2023 · 12 citations · Cited by this paper
  37. Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners · Denise van der Drift · 2023 · 11 citations · Cited by this paper
  38. Implementation of pharmacogenetic testing in pediatric oncology: barriers and facilitators assessment at eight Canadian academic health centres · Jeanette Cooper · 2024 · 10 citations · Cited by this paper
  39. Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs’ Pharmacogenomic Testing for the Veterans (PHASER) Program · Karina Melendez · 2023 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)